Neil A Burns

Neil Burns is the named principal and appears to drive all investment and sourcing decisions directly. His industry blog, *Surfactants Monthly*, serves as both a market-intelligence vehicle and a signal of his personal involvement in evaluating chemical-manufacturing assets. No additional investment committee or partners are publicly disclosed.

Deal flow is anchored to Burns's deep surfactant-industry network, including relationships with chemical producers such as Indovinya, Stepan, Croda, and Syensqo. His continuous publication of *Surfactants Monthly* and speaking engagements — such as the April 2026 CPDA meeting — keep him at the center of industry M&A discussions, allowing him to identify carve-outs and distressed specialty-chemical assets before broader auction processes.

It is categorized as a private equity firm, not a family office. It pursues control-oriented strategies — divestitures, management buyouts, recapitalizations, and spin-offs — in the specialty chemicals sector, which distinguishes it from venture capital or growth-equity models.

The firm's disclosed strategy focuses on direct deals — divestitures, buyouts, and spin-offs. There is no public evidence of fund commitments or a fund-of-funds allocation program.

The firm targets mature industrial assets rather than early-stage ventures. Strategies include management buyouts, corporate divestitures, and recapitalizations of established specialty-chemical manufacturers with existing revenue streams and production capabilities.

Neil Burns serves as a board advisor to Integrity BioChem, a producer of bio-based surfactants. This advisory role creates a direct link to one of the commercial leaders in the bio-surfactant field, though it does not necessarily imply an equity position by the firm.

The source of the firm's investment capital is not publicly disclosed. No regulatory filings or press reports specify whether Burns deploys personal capital, institutional commitments, or partnership structures.